DNA sequencing versus standard prenatal aneuploidy screening.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In high-risk pregnant women, noninvasive prenatal testing with the use of massively parallel sequencing of maternal plasma cell-free DNA (cfDNA testing) accurately detects fetal autosomal aneuploidy. Its performance in low-risk women is unclear.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): N Engl J Med

Title: The New England journal of medicine

Publisher: Massachusetts Medical Society

ISSN (Electronic): 1533-4406

ISSN (Print): 0028-4793

Publication date (Electronic): Feb 27 2014

Volume: 370

Issue: 9

Affiliations

[1 ] From the Mother Infant Research Institute, Tufts Medical Center and Tufts University School of Medicine, Boston (D.W.B.); Lyndhurst Clinical Research, Winston-Salem, NC (R.L.P.); the Group for Women, Norfolk, VA (J.W.); Long Island Jewish Medical Center, North Shore-LIJ Health Systems, New Hyde Park, NY (R.M.); West Coast OB/GYN, San Diego (C.S.), InClin, San Mateo (A.F.D.), and Illumina, Redwood City (D.I.C., P.L.D., K.W.J., K.O., R.P.R., A.J.S.) - all in California; and Colorado Permanente Medical Group, Denver (J.A.C.).

Article

DOI: 10.1056/NEJMoa1311037

PubMed ID: 24571752

SO-VID: 1a60cc54-bb09-4ac8-9730-6e37b4f0ef46

History

Data availability:

Comments

Comment on this article

scite_

Cited by 197

See all cited by

- Version 1